GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NurExone Biologic Inc (FRA:J90) » Definitions » Institutional Ownership

NurExone Biologic (FRA:J90) Institutional Ownership : 0.00% (As of Dec. 12, 2024)


View and export this data going back to 2022. Start your Free Trial

What is NurExone Biologic Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NurExone Biologic's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NurExone Biologic's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NurExone Biologic's Float Percentage Of Total Shares Outstanding is 0.00%.

NurExone Biologic Institutional Ownership Historical Data

The historical data trend for NurExone Biologic's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NurExone Biologic Institutional Ownership Chart

NurExone Biologic Annual Data
Trend Dec21 Dec22 Dec23
Institutional Ownership
- - -

NurExone Biologic Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Institutional Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NurExone Biologic Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

NurExone Biologic Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NurExone Biologic Inc (FRA:J90) » Definitions » Institutional Ownership
Comparable Companies
NEOE:BMND XCNQ:COOL XCNQ:PHRM TSX:RVX TSX:MDNA XCNQ:MDMA XCNQ:ASEP TSXV:QPT XCNQ:TELI TSX:AEZS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
NRXBF:USA NRX:Canada
Address
1 Adelaide St. East, Suite 801, Toronto, ON, CAN, M5C 2V9
Website
https://www.nurexone.com
NurExone Biologic Inc is a company that focuses on developing innovative, biological and minimally invasive treatments for Spinal Cord Injury and Traumatic Brain Injury. Their primary product is ExoTherapy, which is an exosome therapy production platform. The company has two business lines. Firstly, it is developing ExoPTEN, a product that utilizes ExoTherapy for the treatment of acute Spinal Cord Injuries (SCI). Secondly, it aims to monetize its proprietary ExoTherapy technology and production platform by licensing it to the global biopharmaceutical industry for other diseases and indications.

NurExone Biologic Headlines

No Headlines